Sherr CJ - Search Results

1

Host thiopurine methyltransferase status affects mercaptopurine antileukemic effectiveness in a murine model.

Ramsey LB, Janke LJ, Edick MJ, Cheng C, Williams RT, Sherr CJ, Evans WE, Relling MV. Ramsey LB, et al. Among authors: sherr cj. Pharmacogenet Genomics. 2014 May;24(5):263-71. doi: 10.1097/FPC.0000000000000044. Pharmacogenet Genomics. 2014. PMID: 24710003 Free PMC article.

2

The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.

Williams RT, Sherr CJ. Williams RT, et al. Among authors: sherr cj. Cold Spring Harb Symp Quant Biol. 2008;73:461-7. doi: 10.1101/sqb.2008.73.039. Epub 2008 Nov 21. Cold Spring Harb Symp Quant Biol. 2008. PMID: 19028987 Review.

3

Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.

Williams RT, Roussel MF, Sherr CJ. Williams RT, et al. Among authors: sherr cj. Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6688-93. doi: 10.1073/pnas.0602030103. Epub 2006 Apr 17. Proc Natl Acad Sci U S A. 2006. PMID: 16618932 Free PMC article.

4

The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.

Williams RT, Sherr CJ. Williams RT, et al. Among authors: sherr cj. Adv Exp Med Biol. 2007;604:107-14. doi: 10.1007/978-0-387-69116-9_9. Adv Exp Med Biol. 2007. PMID: 17695724 Review.

5

Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia.

Williams RT, den Besten W, Sherr CJ. Williams RT, et al. Among authors: sherr cj. Genes Dev. 2007 Sep 15;21(18):2283-7. doi: 10.1101/gad.1588607. Epub 2007 Aug 30. Genes Dev. 2007. PMID: 17761812 Free PMC article.

6

Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL.

Mullighan CG, Williams RT, Downing JR, Sherr CJ. Mullighan CG, et al. Among authors: sherr cj. Genes Dev. 2008 Jun 1;22(11):1411-5. doi: 10.1101/gad.1673908. Genes Dev. 2008. PMID: 18519632 Free PMC article.

7

Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia.

Volanakis EJ, Williams RT, Sherr CJ. Volanakis EJ, et al. Among authors: sherr cj. Blood. 2009 Nov 12;114(20):4451-9. doi: 10.1182/blood-2009-07-233346. Epub 2009 Sep 16. Blood. 2009. PMID: 19759355 Free PMC article.

8

Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Boulos N, Mulder HL, Calabrese CR, Morrison JB, Rehg JE, Relling MV, Sherr CJ, Williams RT. Boulos N, et al. Among authors: sherr cj. Blood. 2011 Mar 31;117(13):3585-95. doi: 10.1182/blood-2010-08-301267. Epub 2011 Jan 24. Blood. 2011. PMID: 21263154 Free PMC article.

9

BCR-ABL and CDKN2A: a dropped connection.

Williams RT, Sherr CJ. Williams RT, et al. Among authors: sherr cj. Nat Rev Cancer. 2008 Jul;8(7):563; author reply 563. doi: 10.1038/nrc2368-c1. Nat Rev Cancer. 2008. PMID: 18574466 No abstract available.

10

Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.

den Besten W, Kuo ML, Williams RT, Sherr CJ. den Besten W, et al. Among authors: sherr cj. Cell Cycle. 2005 Nov;4(11):1593-8. doi: 10.4161/cc.4.11.2174. Epub 2005 Nov 14. Cell Cycle. 2005. PMID: 16205118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

286 results

Search Page

Filters